In Treatment of Coronavirus disease (COVID-19) Coronavirus disease (Covid-19) is a highly infectious disease that is caused by a strain of a virus called coronavirus. The most common symptoms are fever, cough, loss of taste or smell, breathing difficulty, nasal congestion, and diarrhea among others. Favenza 800 Tablet is used to manage these symptoms in mildly to moderately infected individuals and helps you recover from the infection. Favenza 800 Tablet should be taken only if prescribed by a doctor. If you think you have come in contact with a person who has been infected with Covid-19, or if you feel any of these symptoms, consult your doctor immediately.
It is not known whether it is safe to consume alcohol with Favenza 800 Tablet. Please consult your doctor.
Favenza 800 Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Favenza 800 Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
It is not known whether Favenza 800 Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Favenza 800 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Favenza 800 Tablet may be needed. Please consult your doctor.
Favenza 800 Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Favenza 800 Tablet may be needed. Please consult your doctor.
If you miss a dose of Favenza 800 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Afxia Franke Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Akumentis Healthcare Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Intas Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Prekem Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Lupin Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Synokem Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: MSN Laboratories || ₹14.5/tablet (25% cheaper)